These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7555450)

  • 21. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H
    J Clin Gastroenterol; 1988; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gallstone disappearance after extracorporeal lithotripsy and oral bile acid dissolution.
    Ponchon T; Barkun AN; Pujol B; Mestas JL; Lambert R
    Gastroenterology; 1989 Aug; 97(2):457-63. PubMed ID: 2744359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of cholesterol gallstones with litholytic bile acids.
    Salen G; Tint GS; Shefer S
    Gastroenterol Clin North Am; 1991 Mar; 20(1):171-82. PubMed ID: 2022420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral and contact dissolution of gallstones.
    Schoenfield LJ; Marks JW
    Am J Surg; 1993 Apr; 165(4):427-30. PubMed ID: 8480875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Innovations in the diagnosis and treatment of cholelithiasis].
    Ivanchenkova RA; Egorov AV; Leonovich AE; At'kova ER
    Eksp Klin Gastroenterol; 2012; (4):66-73. PubMed ID: 23402157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of recurrent gallstones.
    Lanzini A; Northfield TC
    Baillieres Clin Gastroenterol; 1992 Nov; 6(4):767-83. PubMed ID: 1486214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of recurrence after successful gallstone dissolution].
    Leiss O; von Bergmann K
    Z Gastroenterol; 1991 Jun; 29(6):301-5. PubMed ID: 1926965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral dissolution therapy for cholelithiasis: mix and match.
    Phillips RS; Barkin JS
    Am J Gastroenterol; 1990 Nov; 85(11):1532-3. PubMed ID: 2239886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro dissolution of gallstones with MTBE: correlation with characteristics at CT and MR imaging.
    Baron RL; Kuyper SJ; Lee SP; Rohrmann CA; Shuman WP; Nelson JA
    Radiology; 1989 Oct; 173(1):117-21. PubMed ID: 2780997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissolution of gallstones--when and how?
    Tangedahl T
    Surg Clin North Am; 1979 Oct; 59(5):797-809. PubMed ID: 390740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
    Polli EE; Bianchi PA; Conte D; Sironi L
    Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
    Pérez Aguilar F; Breto M; del Val A; Berenguer J
    An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
    Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
    J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early gallstone recurrence rate after successful shock-wave therapy.
    Sackmann M; Ippisch E; Sauerbruch T; Holl J; Brendel W; Paumgartner G
    Gastroenterology; 1990 Feb; 98(2):392-6. PubMed ID: 2295394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of ursodeoxycholic acid for dissolution of gallstone fragments: comparison with the combination of ursodeoxycholic acid and chenodeoxycholic acid.
    Sackmann M; Pauletzki J; Aydemir U; Holl J; Sauerbruch T; Hasford J; Paumgartner G
    Hepatology; 1991 Dec; 14(6):1136-41. PubMed ID: 1959863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.